• Wondering if Onto Innovation stock still offers value after a strong run, or if you might be turning up late to the story.
• The share price closed at US$263.12, with the stock down 5.0% over the last week and 10.8% over the last month, yet still up 58.6% year to date and 178.1% over the past year.
• These moves have kept Onto Innovation on many investors' watchlists, as attention often shifts when a stock shows strong multi period returns alongside short term pullbacks. Recent coverage has focused on how the company fits into the broader semiconductor sector and what that might mean for future demand and capital allocation.
• Despite the share price performance, Onto Innovation currently scores just 1/6 on our valuation checks. This sets up a closer look at how different valuation approaches judge the stock today and hints at an even richer way to think about valuation at the end of this article.

Onto Innovation scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Onto Innovation Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model takes projections of a company’s future cash flows and discounts them back to today’s dollars, aiming to estimate what the business might be worth based on those cash flows.

For Onto Innovation, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections. The latest twelve month Free Cash Flow is reported at about $234.7 million. Analyst estimates and subsequent extrapolations suggest Free Cash Flow could reach $833.5 million in 2030, with annual figures stepping up over the coming decade as set out in the ten year projections.

After discounting those future cash flows, the DCF model arrives at an estimated intrinsic value of $214.62 per share. Compared with the recent share price of $263.12, this implies the stock is about 22.6% above the DCF estimate, which indicates it is trading at a premium to this particular cash flow based calculation.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Onto Innovation may be overvalued by 22.6%. Discover 51 high quality undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Onto Innovation Price vs Earnings

For profitable companies, the P/E ratio is a useful way to think about what you are paying for each dollar of earnings, which makes it a common anchor for comparing stocks that already generate profits.

What counts as a “fair” P/E depends on how the market views a company’s growth prospects and risk. Higher expected growth or lower perceived risk can justify a higher multiple, while slower growth or higher risk usually points to a lower one.

Onto Innovation currently trades on a P/E of 123.0x. This sits above the Semiconductor industry average of 63.0x and also above the peer group average of 76.4x, so on simple comparisons the stock carries a premium.

Simply Wall St’s “Fair Ratio” is a proprietary estimate of what P/E might be reasonable for Onto Innovation, at 58.4x, based on factors such as earnings growth, industry, profit margins, market cap and specific risks. Because it adjusts for these company level characteristics, the Fair Ratio can give a more tailored view than broad peer or industry averages.

Comparing the Fair Ratio of 58.4x with the current P/E of 123.0x suggests the stock is trading well above this tailored benchmark.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 20 top founder-led companies.

Upgrade Your Decision Making: Choose your Onto Innovation Narrative

Earlier it was mentioned that there is an even better way to think about valuation. This is where Narratives come in, letting you attach a clear story about Onto Innovation to your own assumptions for future revenue, earnings, margins and fair value. You can then compare that fair value with the live share price in an easy tool on Simply Wall St’s Community page. Narratives are updated when new news or earnings arrive and can differ widely. For example, one Onto Innovation Narrative may anchor on a fair value of about US$220 based on more cautious forecasts, while another leans closer to around US$380 on more optimistic assumptions. This gives you a simple way to see where your view sits and how that might guide your decisions.

For Onto Innovation however we will make it really easy for you with previews of two leading Onto Innovation narratives:

First up is a bullish take that leans into the AI packaging theme and sees more upside potential if the thesis plays out over time.

Fair value in this bullish narrative: US$380.

Based on that fair value, the stock is trading about 30.7% below the narrative fair value relative to the current price of US$263.12.

Revenue growth used in this narrative: 19.93%.

• Frames Onto Innovation as a key supplier at the AI packaging bottleneck, with tools like Dragonfly aimed at advanced packaging and HBM inspection.
• Highlights qualification with TSMC, HBM exposure and Semilab integration as reasons some investors see room for a higher valuation multiple over time.
• Points to execution, competition, export controls and semiconductor cycles as important risks that could challenge the bullish case.

On the other side is a more cautious view that accepts growth but questions how much investors should be willing to pay for it today.

Fair value in this bearish narrative: US$220.

Based on that fair value, the stock is trading about 19.6% above the narrative fair value relative to the current price of US$263.12.

Revenue growth used in this narrative: 18.65%.

• Focuses on rising costs, regulatory demands and customer concentration that could pressure margins and make earnings more volatile.
• Assumes Onto Innovation still grows earnings and revenue, but on terms that support a lower P/E multiple and lower fair value than more optimistic views.
• Emphasises that stronger AI packaging demand, Semilab benefits and diversified products could invalidate a cautious stance if they track better than feared.

These two narratives sit at different ends of the current debate around Onto Innovation. This gives you a clear way to decide which assumptions feel closer to your own expectations for growth, margins and appropriate valuation.

Do you think there's more to the story for Onto Innovation? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.